US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Takeda Pharmaceutical Co Ltd

18.04

+0.18001.01%

Post-market: 18.03-0.0100-0.06%19:52 EDT

Volume:3.25M

Turnover:58.58M

Market Cap:56.99B

PE:80.28

High:18.12

Open:17.79

Low:17.78

Close:17.86

52wk High:18.82

52wk Low:12.99

Shares:3.16B

Float Shares:3.06B

Volume Ratio:1.12

T/O Rate:0.11%

Dividend:0.62

Dividend Rate:3.45%

EPS(TTM):0.2247

EPS(LYR):0.2245

ROE:1.50%

ROA:2.47%

PB:1.19

PE(LYR):80.36

Loading ...

Overview Company News Filings

Leerink views ‘major deal’ on Entyvio as positive for Halozyme

Halozyme announces global collaboration, license agreement with Takeda

Takeda Pharmaceuticals Shares Rise on Positive Psoriasis Treatment Results

Takeda Pharmaceutical's Potential Plaque Psoriasis Therapy Meets Endpoints in Phase 3 Studies

MT Newswires Live

INNOVENT BIO (01801) Completes Global Strategic Collaboration with Takeda Pharmaceutical and Issues 6.9138 Million Shares Under General Mandate

FDA Flags Antibody Risk After Child's Death Linked To Takeda's Enzyme Replacement Therapy For Rare Blood Disorder

Benzinga_recent_news

Takeda Pharmaceutical's Adzynma Under US FDA Probe Following Death of Pediatric Patient

MT Newswires Live

Immigration Declares 'No Safe Haven' in Indonesia for International Criminals Following Major Arrests

Neurocrine Biosciences' Depressive Disorder Drug Fails to Meet Primary Goal in Phase 2 Study

MT Newswires Live

Takeda presents interim data from Phase 1b study of mezagitamab

Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading

MT Newswires Live

Stock Track | Takeda Pharmaceutical Plummets 5.08% as Q2 Earnings Miss Estimates and Company Lowers Outlook

Takeda Pharmaceutical's Fiscal Q2 Core Earnings, Revenue Decline; Fiscal 2025 Outlook Trimmed

MT Newswires Live

Takeda Swings to Loss on Impairment Charges, Cuts Guidance -- Update

Press Release: Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year

Zhao Yin International Raises Target Price for INNOVENT BIO (01801) to HKD 110.62 Following Strategic Partnership with Takeda Pharmaceutical Co Ltd

Haitong International: Innovent Biologics (01801) and Takeda Pharmaceutical Co Ltd Reach $11.4 Billion Deal, Collaboration on Commercialization Looks Promising

LCB: INNOVENT BIO (01801) and Takeda Pharmaceutical's Collaboration Positively Impacts Product Development, Target Price Raised to HKD 120.1

Hong Kong Stock Market Update | Innovent Bio and Takeda Pharmaceutical Reach Global Strategic Cooperation and Issue Shares Under General Authorization

Takeda Forms $1.2 Billion Strategic Partnership with Innovent Biologics

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TAK/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"TAK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","market":"US","secType":"STK","nameCN":"Takeda Pharmaceutical Co Ltd","latestPrice":18.04,"timestamp":1774382400000,"preClose":17.86,"halted":0,"volume":3251373,"hourTrading":{"tag":"盘后","latestPrice":18.03,"preClose":18.04,"latestTime":"19:52 EDT","volume":75996,"amount":1367960.55,"timestamp":1774396363082,"change":-0.01,"changeRate":-0.000554,"amplitude":0.002217},"delay":0,"changeRate":0.010078387458006703,"floatShares":3057000000,"shares":3159188548,"eps":0.224727,"marketStatus":"Not Yet Opened","change":0.18,"latestTime":"03-24 16:00:00 EDT","open":17.79,"high":18.115,"low":17.78,"amount":58584292.158852,"amplitude":0.018757,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.224727,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774425600000},"marketStatusCode":0,"adr":0,"adrRate":0.5,"listingDate":1545627600000,"exchange":"NYSE","adjPreClose":17.86,"dividendRate":0.035177,"preHourTrading":{"tag":"盘前","latestPrice":17.86,"preClose":17.86,"latestTime":"08:03 EDT","volume":4,"amount":72.3688,"timestamp":1774353781827,"change":0,"changeRate":0,"amplitude":0.052004},"postHourTrading":{"tag":"盘后","latestPrice":18.03,"preClose":18.04,"latestTime":"19:52 EDT","volume":75996,"amount":1367960.55,"timestamp":1774396363082,"change":-0.01,"changeRate":-0.000554,"amplitude":0.002217},"volumeRatio":1.122154,"impliedVol":0.364,"impliedVolPercentile":0.6295},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","floatShares":3057000000,"roa":"2.47%","roe":"1.50%","lyrEps":0.224477,"volumeRatio":1.122154,"shares":3159188548,"dividePrice":0.622512,"high":18.115,"amplitude":0.018757,"preClose":17.86,"low":17.78,"week52Low":12.99,"pbRate":"1.19","psRate":"2.03","week52High":18.82,"institutionHeld":0.1061,"latestPrice":18.04,"eps":0.224727,"divideRate":0.034507,"volume":3251373,"delay":0,"ttmEps":0.224727,"open":17.79,"prevYearClose":15.59,"prevWeekClose":17.83,"prevMonthClose":18.75,"prevQuarterClose":15.59,"fiveDayClose":18.39,"twentyDayClose":18.65,"sixtyDayClose":15.58},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TAK\",params:#limit:5,,,undefined,":[{"date":"2026-05-13","symbol":"TAK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778659200000,"name":null,"time":"Pre-Market","dateTimestamp":1778644800000,"actualEps":null},{"market":"US","date":"2026-01-29","symbol":"TAK","fiscalQuarterEnding":"2025/12","expectedEps":0.55,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1769662800000,"reportTimeType":"pre","actualEps":0.48},{"date":"2025-10-30","symbol":"TAK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":0.44,"defaultRemindTime":1761811200000,"name":null,"time":"Pre-Market","dateTimestamp":1761796800000,"actualEps":0.44},{"market":"US","date":"2025-07-30","symbol":"TAK","fiscalQuarterEnding":"2025/06","expectedEps":0.47,"name":null,"time":"","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"","actualEps":0.52},{"market":"US","date":"2025-01-30","symbol":"TAK","fiscalQuarterEnding":"2024/12","expectedEps":0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738213200000,"reportTimeType":"pre","actualEps":0.42}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TAK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TAK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1689307200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TAK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TAK","date":"2026-03-23","current":80.275178,"percent":0.9288,"low":9.919003,"twenty":15.819699,"median":29.842804,"eighty":45.869165,"high":247.195474,"avg":40.535918,"sd":43.955818,"marketCap":55478980895.4},"quantilePoints":[{"date":"2021-03-26","current":36.385479,"twenty":30.34278,"median":42.069006,"eighty":92.219192,"marketCap":59972674222.12},{"date":"2021-04-01","current":35.38287,"twenty":30.371454,"median":41.476727,"eighty":92.150961,"marketCap":57783874962.89},{"date":"2021-04-09","current":32.481215,"twenty":30.393667,"median":38.431569,"eighty":92.111972,"marketCap":53478879478.89},{"date":"2021-04-16","current":32.082779,"twenty":30.470959,"median":38.377853,"eighty":92.111972,"marketCap":53250001858.4},{"date":"2021-04-23","current":31.900884,"twenty":30.513064,"median":38.294386,"eighty":92.058362,"marketCap":53341682665.94},{"date":"2021-04-30","current":31.485125,"twenty":30.533079,"median":38.21414,"eighty":91.833434,"marketCap":52029509066.16},{"date":"2021-05-07","current":31.831591,"twenty":30.534382,"median":38.169603,"eighty":91.791488,"marketCap":52970833572.63},{"date":"2021-05-14","current":15.564762,"twenty":30.470959,"median":38.145677,"eighty":91.758112,"marketCap":53496176267.97},{"date":"2021-05-21","current":15.876889,"twenty":30.319318,"median":38.091991,"eighty":91.609986,"marketCap":54795356598.76},{"date":"2021-05-28","current":15.664642,"twenty":30.236167,"median":38.041392,"eighty":91.546628,"marketCap":53587690959.61},{"date":"2021-06-04","current":15.281766,"twenty":30.057838,"median":37.818162,"eighty":91.527134,"marketCap":52499044333.6},{"date":"2021-06-11","current":15.732274,"twenty":29.940017,"median":37.70687,"eighty":91.283451,"marketCap":53886220157.49},{"date":"2021-06-18","current":15.499142,"twenty":29.705398,"median":37.644832,"eighty":91.259083,"marketCap":52855138856.99},{"date":"2021-06-25","current":15.64495,"twenty":29.653254,"median":37.496711,"eighty":91.185978,"marketCap":53110087882.29},{"date":"2021-07-02","current":15.624135,"twenty":29.556114,"median":37.309512,"eighty":90.966664,"marketCap":52790633079.89},{"date":"2021-07-09","current":15.170356,"twenty":29.369182,"median":37.239049,"eighty":90.713234,"marketCap":51765371608.86},{"date":"2021-07-16","current":15.553362,"twenty":29.036801,"median":37.034171,"eighty":90.649877,"marketCap":53089153550.44},{"date":"2021-07-23","current":15.445121,"twenty":28.610503,"median":36.990446,"eighty":90.630383,"marketCap":52540828243.5},{"date":"2021-07-30","current":13.400212,"twenty":26.987384,"median":36.968687,"eighty":90.397999,"marketCap":52641482781.37},{"date":"2021-08-06","current":13.231512,"twenty":25.788836,"median":36.881192,"eighty":90.295707,"marketCap":51739766156.6},{"date":"2021-08-13","current":13.399277,"twenty":25.542527,"median":36.851251,"eighty":90.284353,"marketCap":52624385513.69},{"date":"2021-08-20","current":13.340924,"twenty":25.375364,"median":36.822486,"eighty":90.167386,"marketCap":52391869685.63},{"date":"2021-08-27","current":13.304453,"twenty":25.07978,"median":36.81694,"eighty":90.040671,"marketCap":52184954198.97},{"date":"2021-09-03","current":13.585277,"twenty":24.895379,"median":36.800541,"eighty":89.938325,"marketCap":53414238064.1},{"date":"2021-09-10","current":13.6801,"twenty":24.732641,"median":36.787118,"eighty":89.91883,"marketCap":53684261064.92},{"date":"2021-09-17","current":13.906217,"twenty":24.583535,"median":36.72461,"eighty":89.874967,"marketCap":54565644835.19},{"date":"2021-09-24","current":13.753041,"twenty":24.444102,"median":36.66065,"eighty":89.831104,"marketCap":53563443001.25},{"date":"2021-10-01","current":13.260689,"twenty":24.187434,"median":36.617455,"eighty":89.777494,"marketCap":51482210756.95},{"date":"2021-10-08","current":11.666926,"twenty":23.93319,"median":36.601121,"eighty":89.748252,"marketCap":44862900501.13},{"date":"2021-10-15","current":11.787279,"twenty":23.7033,"median":36.578836,"eighty":89.499696,"marketCap":44516597060.99},{"date":"2021-10-22","current":11.681514,"twenty":23.539863,"median":36.5454,"eighty":88.968468,"marketCap":44293684279.19},{"date":"2021-10-29","current":10.648321,"twenty":23.423498,"median":36.488155,"eighty":88.710165,"marketCap":44164269191.12},{"date":"2021-11-05","current":10.784625,"twenty":23.226892,"median":36.468627,"eighty":88.627312,"marketCap":44983557825.66},{"date":"2021-11-12","current":10.950849,"twenty":22.951173,"median":36.398869,"eighty":88.490851,"marketCap":45493195113.2},{"date":"2021-11-19","current":10.728109,"twenty":22.593579,"median":36.365388,"eighty":88.33002,"marketCap":44596449686.83},{"date":"2021-11-26","current":10.425581,"twenty":22.055183,"median":36.25968,"eighty":88.252042,"marketCap":43512424769.26},{"date":"2021-12-03","current":10.106651,"twenty":21.515452,"median":36.172679,"eighty":88.178937,"marketCap":42286529642.36},{"date":"2021-12-10","current":10.142864,"twenty":21.321368,"median":36.088488,"eighty":87.847529,"marketCap":42348534488.31},{"date":"2021-12-17","current":10.34424,"twenty":21.015505,"median":36.02197,"eighty":87.423521,"marketCap":43082485607.36},{"date":"2021-12-23","current":10.363994,"twenty":20.795645,"median":35.82744,"eighty":87.174965,"marketCap":42874132957.12},{"date":"2021-12-31","current":10.327779,"twenty":20.657578,"median":35.632629,"eighty":86.517022,"marketCap":42437110052.52},{"date":"2022-01-07","current":10.522022,"twenty":20.640925,"median":35.562823,"eighty":86.434171,"marketCap":43033429977.32},{"date":"2022-01-14","current":11.009273,"twenty":20.536864,"median":35.556871,"eighty":86.322076,"marketCap":45750368973.66},{"date":"2022-01-21","current":10.940136,"twenty":20.171308,"median":35.520843,"eighty":86.263593,"marketCap":45488233052.08},{"date":"2022-01-28","current":10.953305,"twenty":19.949589,"median":35.455688,"eighty":85.922437,"marketCap":44994125510.56},{"date":"2022-02-04","current":12.019761,"twenty":19.86233,"median":35.393845,"eighty":85.355005,"marketCap":45736794370.02},{"date":"2022-02-11","current":12.502153,"twenty":19.831282,"median":35.308236,"eighty":85.302091,"marketCap":47298200126.65},{"date":"2022-02-18","current":12.558981,"twenty":19.671006,"median":35.308236,"eighty":85.302091,"marketCap":47834673171.52},{"date":"2022-02-25","current":12.196703,"twenty":19.550551,"median":35.308236,"eighty":85.302091,"marketCap":46263555485.74},{"date":"2022-03-04","current":12.289048,"twenty":19.380891,"median":35.308236,"eighty":85.302091,"marketCap":46976698663.99},{"date":"2022-03-11","current":12.043978,"twenty":19.117196,"median":35.308236,"eighty":85.302091,"marketCap":45095629553.81},{"date":"2022-03-18","current":12.707196,"twenty":18.980245,"median":35.308236,"eighty":85.302091,"marketCap":46769031069.82},{"date":"2022-03-25","current":12.770838,"twenty":18.858799,"median":35.308236,"eighty":85.302091,"marketCap":45895036970.15},{"date":"2022-04-01","current":12.530413,"twenty":18.69121,"median":35.308236,"eighty":85.302091,"marketCap":44742437445.66},{"date":"2022-04-08","current":13.064299,"twenty":18.623126,"median":35.308236,"eighty":85.302091,"marketCap":46073289723.14},{"date":"2022-04-14","current":13.294114,"twenty":18.443795,"median":35.308236,"eighty":85.302091,"marketCap":46294767383.12},{"date":"2022-04-22","current":13.21633,"twenty":18.221438,"median":35.308236,"eighty":85.302091,"marketCap":45025239824.55},{"date":"2022-04-29","current":13.325935,"twenty":17.979017,"median":35.308236,"eighty":85.302091,"marketCap":45022632781.95},{"date":"2022-05-06","current":13.53454,"twenty":17.700642,"median":35.308236,"eighty":85.302091,"marketCap":45566277364},{"date":"2022-05-13","current":24.629857,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":43848144051.53},{"date":"2022-05-20","current":25.018997,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45016426783.75},{"date":"2022-05-27","current":25.119636,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45470626890.48},{"date":"2022-06-03","current":24.280973,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":42728413394.89},{"date":"2022-06-10","current":24.368194,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":41777808638.38},{"date":"2022-06-17","current":23.83145,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":40560767412.66},{"date":"2022-06-24","current":24.871564,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42352646298.73},{"date":"2022-07-01","current":25.220478,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42911856821.29},{"date":"2022-07-08","current":26.059148,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44046297256.04},{"date":"2022-07-15","current":26.763631,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44459950529.79},{"date":"2022-07-22","current":26.817305,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45321441244.41},{"date":"2022-07-29","current":30.743571,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45477961048.28},{"date":"2022-08-05","current":29.247514,"twenty":15.868566,"median":35.251678,"eighty":85.31532,"marketCap":42639852719.36},{"date":"2022-08-12","current":29.748811,"twenty":15.868566,"median":35.071486,"eighty":85.31532,"marketCap":43951767417.68},{"date":"2022-08-19","current":29.8898,"twenty":15.868566,"median":34.741035,"eighty":85.31532,"marketCap":43038704613},{"date":"2022-08-26","current":29.874135,"twenty":15.868566,"median":33.797644,"eighty":85.31532,"marketCap":42969756201.7},{"date":"2022-09-02","current":30.022957,"twenty":15.868566,"median":32.525364,"eighty":85.31532,"marketCap":42304023842.38},{"date":"2022-09-09","current":30.65741,"twenty":15.868566,"median":32.307982,"eighty":85.31532,"marketCap":42457872052.31},{"date":"2022-09-16","current":30.406762,"twenty":15.868566,"median":32.13589,"eighty":85.31532,"marketCap":41975860478.2},{"date":"2022-09-23","current":29.784868,"twenty":15.868566,"median":32.082779,"eighty":85.31532,"marketCap":41053322910.74},{"date":"2022-09-30","current":29.611929,"twenty":15.868566,"median":31.991351,"eighty":85.31532,"marketCap":40398024705.55},{"date":"2022-10-07","current":29.784868,"twenty":15.868566,"median":31.910861,"eighty":85.31532,"marketCap":40490115913.28},{"date":"2022-10-14","current":30.091442,"twenty":15.868566,"median":31.822929,"eighty":85.31532,"marketCap":40007811364.69},{"date":"2022-10-21","current":29.234607,"twenty":15.868566,"median":31.680102,"eighty":85.31532,"marketCap":38943108088.84},{"date":"2022-10-28","current":27.96678,"twenty":15.868566,"median":31.562866,"eighty":85.31532,"marketCap":40412932074.34},{"date":"2022-11-04","current":27.990228,"twenty":15.868566,"median":31.51076,"eighty":85.31532,"marketCap":40544936411.09},{"date":"2022-11-11","current":28.209015,"twenty":15.868566,"median":31.374814,"eighty":85.31532,"marketCap":43206259311.05},{"date":"2022-11-18","current":28.704934,"twenty":15.868566,"median":31.254645,"eighty":85.31532,"marketCap":43730486647.27},{"date":"2022-11-25","current":29.426933,"twenty":15.868566,"median":31.201154,"eighty":85.31532,"marketCap":45057111010.77},{"date":"2022-12-02","current":28.931014,"twenty":15.868566,"median":31.037761,"eighty":85.31532,"marketCap":45570767384.44},{"date":"2022-12-09","current":29.835336,"twenty":15.868566,"median":30.937343,"eighty":85.31532,"marketCap":46637499358.3},{"date":"2022-12-16","current":30.331255,"twenty":15.868566,"median":30.871973,"eighty":85.31532,"marketCap":47313819017.43},{"date":"2022-12-23","current":29.900973,"twenty":15.868566,"median":30.772934,"eighty":85.31532,"marketCap":47996239753.01},{"date":"2022-12-30","current":29.981195,"twenty":15.868566,"median":30.71556,"eighty":85.31532,"marketCap":48463304453.77},{"date":"2023-01-06","current":29.755114,"twenty":15.868566,"median":30.572454,"eighty":85.31532,"marketCap":47870974965.36},{"date":"2023-01-13","current":29.864508,"twenty":15.868566,"median":30.484406,"eighty":85.31532,"marketCap":49882681588.13},{"date":"2023-01-20","current":30.426063,"twenty":15.868566,"median":30.426063,"eighty":85.31532,"marketCap":49943652563.58},{"date":"2023-01-27","current":30.148932,"twenty":15.868566,"median":30.406762,"eighty":85.31532,"marketCap":49467797966.47},{"date":"2023-02-03","current":23.618692,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49524315647.28},{"date":"2023-02-10","current":23.884908,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49885153889.85},{"date":"2023-02-17","current":23.681054,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48373362782.36},{"date":"2023-02-24","current":23.799969,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":47942402215.74},{"date":"2023-03-03","current":24.043461,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48450666632.88},{"date":"2023-03-10","current":24.621048,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50074775527.78},{"date":"2023-03-17","current":24.802252,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51520828536.51},{"date":"2023-03-24","current":24.139732,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50698940566.02},{"date":"2023-03-31","current":24.63238,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":50868882296.85},{"date":"2023-04-06","current":24.898523,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":51908951328.51},{"date":"2023-04-14","current":25.289243,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52430478946.56},{"date":"2023-04-21","current":25.436471,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52090554629.18},{"date":"2023-04-28","current":25.549723,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52360758781.69},{"date":"2023-05-05","current":25.934781,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":53114594501.1},{"date":"2023-05-12","current":21.816188,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51463307525.88},{"date":"2023-05-19","current":21.919152,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50148262100.11},{"date":"2023-05-26","current":22.174322,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50264110513.18},{"date":"2023-06-02","current":21.909524,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50016322403.86},{"date":"2023-06-09","current":22.247876,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50740318667.02},{"date":"2023-06-16","current":22.419504,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50575421543.16},{"date":"2023-06-23","current":22.547244,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":50034367985.85},{"date":"2023-06-30","current":22.199081,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48652831553.96},{"date":"2023-07-07","current":21.625347,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47542321682.04},{"date":"2023-07-14","current":21.105555,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48436114801.39},{"date":"2023-07-21","current":21.512562,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48597606707.51},{"date":"2023-07-28","current":22.302484,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47655983749.28},{"date":"2023-08-04","current":22.405905,"twenty":15.864404,"median":30.349157,"eighty":85.328548,"marketCap":47472091400.73},{"date":"2023-08-11","current":22.962958,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47925971293.26},{"date":"2023-08-18","current":22.653484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":46744998549.67},{"date":"2023-08-25","current":22.947484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47472892956.93},{"date":"2023-09-01","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":48142626644.03},{"date":"2023-09-08","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":47619131084.19},{"date":"2023-09-15","current":25.06738,"twenty":15.864404,"median":30.239629,"eighty":85.328548,"marketCap":51339735089.9},{"date":"2023-09-22","current":24.298853,"twenty":15.864404,"median":30.152523,"eighty":85.328548,"marketCap":49671905160.78},{"date":"2023-09-29","current":23.9378,"twenty":15.864404,"median":30.101284,"eighty":85.328548,"marketCap":48306094881.06},{"date":"2023-10-06","current":23.12801,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":46912236069.61},{"date":"2023-10-13","current":23.4478,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":47185225879.19},{"date":"2023-10-20","current":22.447168,"twenty":15.864404,"median":30.035164,"eighty":85.328548,"marketCap":45133632614.81},{"date":"2023-10-27","current":33.018744,"twenty":15.848805,"median":30.061417,"eighty":85.468491,"marketCap":42045438777.36},{"date":"2023-11-03","current":33.977052,"twenty":15.848805,"median":30.109117,"eighty":85.468491,"marketCap":43262280273.82},{"date":"2023-11-10","current":34.001614,"twenty":15.848805,"median":30.156114,"eighty":85.468491,"marketCap":43146195810.29},{"date":"2023-11-17","current":34.509223,"twenty":15.848805,"median":30.265619,"eighty":85.468491,"marketCap":43924997173.45},{"date":"2023-11-24","current":34.411351,"twenty":15.848805,"median":30.338548,"eighty":85.468491,"marketCap":44071202551.42},{"date":"2023-12-01","current":34.149357,"twenty":15.848805,"median":30.406762,"eighty":85.468491,"marketCap":44271809028.5},{"date":"2023-12-08","current":33.224188,"twenty":15.856081,"median":30.46982,"eighty":85.355005,"marketCap":44164475676.92},{"date":"2023-12-15","current":32.708387,"twenty":15.856081,"median":30.676992,"eighty":85.355005,"marketCap":44261463171.18},{"date":"2023-12-22","current":32.732997,"twenty":15.856081,"median":31.207345,"eighty":85.355005,"marketCap":44132705649.12},{"date":"2023-12-29","current":33.191488,"twenty":15.848805,"median":31.270394,"eighty":85.468491,"marketCap":45078827041.22},{"date":"2024-01-05","current":35.107326,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46553386498.52},{"date":"2024-01-12","current":35.467569,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46529118760.4},{"date":"2024-01-19","current":35.574004,"twenty":15.834252,"median":31.485125,"eighty":85.695464,"marketCap":46054562134.98},{"date":"2024-01-26","current":35.287452,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45813893702.51},{"date":"2024-02-02","current":37.669312,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45919514328.61},{"date":"2024-02-09","current":37.493246,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":44733412617.38},{"date":"2024-02-16","current":38.84015,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46075141205.13},{"date":"2024-02-23","current":39.033823,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46211688108.13},{"date":"2024-03-01","current":38.637675,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45954550562.52},{"date":"2024-03-08","current":38.311953,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":46140815426.08},{"date":"2024-03-15","current":37.871788,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45561442683.96},{"date":"2024-03-22","current":38.796134,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45585981704.56},{"date":"2024-03-28","current":37.000261,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":43584427473.65},{"date":"2024-04-05","current":36.269795,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42616375994.67},{"date":"2024-04-12","current":36.498683,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42430179712.64},{"date":"2024-04-19","current":35.820825,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41294416133.79},{"date":"2024-04-26","current":35.997119,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41249770241.05},{"date":"2024-05-03","current":36.314041,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42076379836.26},{"date":"2024-05-10","current":36.349255,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41627594417.07},{"date":"2024-05-17","current":44.976968,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41733682877.63},{"date":"2024-05-24","current":45.020529,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41285104836.56},{"date":"2024-05-31","current":45.445251,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41644103120.04},{"date":"2024-06-07","current":46.087779,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42404430023},{"date":"2024-06-14","current":45.107651,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41300590483.72},{"date":"2024-06-21","current":43.866156,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":39610552206.76},{"date":"2024-06-28","current":45.436656,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":40691773038.88},{"date":"2024-07-05","current":46.209907,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41429859502.63},{"date":"2024-07-12","current":47.281654,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43144411716.7},{"date":"2024-07-19","current":46.533596,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42599959119.02},{"date":"2024-07-26","current":46.698609,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43774096625.98},{"date":"2024-08-02","current":44.272889,"twenty":15.841528,"median":31.485125,"eighty":84.95809,"marketCap":45300242074.37},{"date":"2024-08-09","current":43.014896,"twenty":15.841528,"median":31.485125,"eighty":84.034079,"marketCap":44025677518.59},{"date":"2024-08-16","current":45.710595,"twenty":15.841528,"median":31.485125,"eighty":83.611233,"marketCap":46246726032.37},{"date":"2024-08-23","current":46.418876,"twenty":15.841528,"median":31.485125,"eighty":83.285679,"marketCap":48080793858.92},{"date":"2024-08-30","current":45.805737,"twenty":15.841528,"median":31.485125,"eighty":82.840382,"marketCap":47110126928.06},{"date":"2024-09-06","current":45.150312,"twenty":15.841528,"median":31.485125,"eighty":82.567216,"marketCap":47633333133.33},{"date":"2024-09-13","current":43.733749,"twenty":15.841528,"median":31.485125,"eighty":82.35018,"marketCap":46692187320.02},{"date":"2024-09-20","current":45.192598,"twenty":15.841528,"median":31.485125,"eighty":81.917164,"marketCap":46914983400.73},{"date":"2024-09-27","current":44.008604,"twenty":15.841528,"median":31.485125,"eighty":81.717782,"marketCap":46173769906.47},{"date":"2024-10-04","current":44.8226,"twenty":15.841528,"median":31.485125,"eighty":81.193902,"marketCap":45207064894.75},{"date":"2024-10-11","current":45.034027,"twenty":15.841528,"median":31.485125,"eighty":80.903118,"marketCap":45273197191.14},{"date":"2024-10-18","current":45.203169,"twenty":15.841528,"median":31.485125,"eighty":80.121066,"marketCap":45314702691.87},{"date":"2024-10-25","current":43.395465,"twenty":15.841528,"median":31.485125,"eighty":79.259288,"marketCap":42802477236.79},{"date":"2024-11-01","current":23.34074,"twenty":15.841528,"median":31.394177,"eighty":76.252009,"marketCap":44255337707.7},{"date":"2024-11-08","current":23.061963,"twenty":15.841528,"median":31.223737,"eighty":52.659045,"marketCap":43818726338.15},{"date":"2024-11-15","current":23.302476,"twenty":15.841528,"median":30.720073,"eighty":52.113395,"marketCap":43649113935.95},{"date":"2024-11-22","current":22.482544,"twenty":15.841528,"median":30.492581,"eighty":51.914978,"marketCap":42094765685.01},{"date":"2024-11-29","current":22.318557,"twenty":15.841528,"median":30.428162,"eighty":51.719171,"marketCap":43004121919.03},{"date":"2024-12-06","current":22.537206,"twenty":15.841528,"median":30.363743,"eighty":51.54686,"marketCap":43593417925.5},{"date":"2024-12-13","current":22.602801,"twenty":15.841528,"median":30.265696,"eighty":51.06387,"marketCap":42654808427.14},{"date":"2024-12-20","current":22.438814,"twenty":15.841528,"median":30.156169,"eighty":50.729692,"marketCap":41620825476.96},{"date":"2024-12-27","current":22.89251,"twenty":15.841528,"median":30.11976,"eighty":50.270198,"marketCap":42157933916.75},{"date":"2025-01-03","current":22.854246,"twenty":15.841528,"median":30.084614,"eighty":49.695831,"marketCap":42120101324.52},{"date":"2025-01-10","current":22.526274,"twenty":15.834252,"median":30.039538,"eighty":48.706353,"marketCap":41387819255.78},{"date":"2025-01-17","current":22.072578,"twenty":15.834252,"median":29.98139,"eighty":47.742982,"marketCap":40954868347.09},{"date":"2025-01-24","current":22.056179,"twenty":15.834252,"median":29.928964,"eighty":47.376261,"marketCap":41086375616.12},{"date":"2025-01-31","current":32.066996,"twenty":15.834252,"median":29.8898,"eighty":47.184847,"marketCap":43068627249.87},{"date":"2025-02-07","current":31.518451,"twenty":15.834252,"median":29.8898,"eighty":46.698609,"marketCap":43370831342.3},{"date":"2025-02-14","current":31.625402,"twenty":15.834252,"median":29.8898,"eighty":46.623803,"marketCap":43271885610.15},{"date":"2025-02-21","current":32.135858,"twenty":15.834252,"median":29.8898,"eighty":46.463276,"marketCap":44737299221.36},{"date":"2025-02-28","current":33.019632,"twenty":15.834252,"median":29.8898,"eighty":46.1861,"marketCap":45710719655.87},{"date":"2025-03-07","current":33.965435,"twenty":15.826975,"median":29.881968,"eighty":45.994515,"marketCap":47968574450.17},{"date":"2025-03-14","current":32.579894,"twenty":15.826975,"median":29.881968,"eighty":45.856479,"marketCap":45709305301.84},{"date":"2025-03-21","current":33.462021,"twenty":15.826975,"median":29.881968,"eighty":45.756962,"marketCap":46697220950.86},{"date":"2025-03-28","current":32.837181,"twenty":15.826975,"median":29.881968,"eighty":45.646342,"marketCap":45537525126.69},{"date":"2025-04-04","current":32.910692,"twenty":15.826975,"median":29.881968,"eighty":45.486482,"marketCap":46959977925.4},{"date":"2025-04-11","current":28.911716,"twenty":15.834252,"median":29.864508,"eighty":45.423604,"marketCap":41903036554.51},{"date":"2025-04-17","current":30.516053,"twenty":15.834252,"median":29.864508,"eighty":45.37687,"marketCap":44665727413.14},{"date":"2025-04-25","current":31.299454,"twenty":15.826975,"median":29.853656,"eighty":45.205165,"marketCap":45236702475.67},{"date":"2025-05-02","current":32.353752,"twenty":15.826975,"median":29.853656,"eighty":45.143969,"marketCap":46627023849.03},{"date":"2025-05-09","current":62.186826,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46246122430},{"date":"2025-05-16","current":59.013194,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":43629573670.78},{"date":"2025-05-23","current":60.272181,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":45243750600.82},{"date":"2025-05-30","current":62.428377,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46713186360.41},{"date":"2025-06-06","current":62.153426,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46690667816.43},{"date":"2025-06-13","current":62.934861,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":47259274399.65},{"date":"2025-06-20","current":62.052124,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45950911927.98},{"date":"2025-06-27","current":63.18087,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47191840400.65},{"date":"2025-07-03","current":64.005724,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47693415916.83},{"date":"2025-07-11","current":64.055104,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47209686047.66},{"date":"2025-07-18","current":63.513752,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46158538139.51},{"date":"2025-07-25","current":63.308916,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46555456308.17},{"date":"2025-08-01","current":48.106805,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43759985637.51},{"date":"2025-08-08","current":48.654381,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45191185373.67},{"date":"2025-08-15","current":50.297108,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46622420863.67},{"date":"2025-08-22","current":52.350517,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":48379407617.45},{"date":"2025-08-29","current":50.434002,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46969989485.26},{"date":"2025-09-05","current":52.179399,"twenty":15.818034,"median":29.83907,"eighty":45.065741,"marketCap":48057469940.35},{"date":"2025-09-12","current":51.255365,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47683369897.6},{"date":"2025-09-19","current":51.084248,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47282912126.15},{"date":"2025-09-26","current":50.627935,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46290416349.68},{"date":"2025-10-03","current":48.574526,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45123442627.46},{"date":"2025-10-10","current":48.163844,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43057554125.18},{"date":"2025-10-17","current":47.810202,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43420086875.26},{"date":"2025-10-24","current":49.008023,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43939898848.11},{"date":"2025-10-31","current":196.128812,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":42096877735.37},{"date":"2025-11-07","current":199.628241,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":43122516182.74},{"date":"2025-11-14","current":212.188582,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45471927947.27},{"date":"2025-11-21","current":211.902035,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":44500274886.11},{"date":"2025-11-28","current":215.197333,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45545101317.81},{"date":"2025-12-05","current":210.61257,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45011991214.34},{"date":"2025-12-12","current":212.427372,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45254225772.44},{"date":"2025-12-19","current":219.877613,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":46788038894.3},{"date":"2025-12-26","current":232.581228,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":49307900125.5},{"date":"2026-01-02","current":230.9097,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":48729268900.59},{"date":"2026-01-09","current":242.610705,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51132650268.4},{"date":"2026-01-16","current":242.276399,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":50569808771.94},{"date":"2026-01-23","current":244.329994,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51041613744.96},{"date":"2026-01-30","current":73.324517,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":54139767928.12},{"date":"2026-02-06","current":77.171186,"twenty":15.819699,"median":29.842804,"eighty":45.118598,"marketCap":55518181293.68},{"date":"2026-02-13","current":78.528012,"twenty":15.819699,"median":29.842804,"eighty":45.203169,"marketCap":58174278066.56},{"date":"2026-02-20","current":80.98988,"twenty":15.819699,"median":29.842804,"eighty":45.358128,"marketCap":59032990935.72},{"date":"2026-02-27","current":81.400335,"twenty":15.819699,"median":29.842804,"eighty":45.393454,"marketCap":58849002644.08},{"date":"2026-03-06","current":79.553824,"twenty":15.819699,"median":29.842804,"eighty":45.478025,"marketCap":56940998250.88},{"date":"2026-03-13","current":79.357982,"twenty":15.819699,"median":29.842804,"eighty":45.710595,"marketCap":56281429903.04},{"date":"2026-03-20","current":80.68691,"twenty":15.819699,"median":29.842804,"eighty":45.805737,"marketCap":57640580474.28},{"date":"2026-03-23","current":78.021155,"twenty":15.819699,"median":29.842804,"eighty":45.869165,"marketCap":55478980895.4}],"updateTime":1774420739291},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TAK\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2602392072","title":"Leerink views ‘major deal’ on Entyvio as positive for Halozyme","url":"https://stock-news.laohu8.com/highlight/detail?id=2602392072","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602392072?lang=en_us&edition=fundamental","pubTime":"2026-01-09 02:40","pubTimestamp":1767897615,"startTime":"0","endTime":"0","summary":"Leerink notes Halozyme (HALO) issued a press release announcing that it entered into an exclusive license agreement with Takeda (TAK) in December 2...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/leerink-views-major-deal-on-entyvio-as-positive-for-halozyme-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/leerink-views-major-deal-on-entyvio-as-positive-for-halozyme-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HALO","BK4007","TAK","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2601536282","title":"Halozyme announces global collaboration, license agreement with Takeda","url":"https://stock-news.laohu8.com/highlight/detail?id=2601536282","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601536282?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:11","pubTimestamp":1767877904,"startTime":"0","endTime":"0","summary":"Halozyme Therapeutics (HALO) announced the company entered into a global collaboration and exclusive license agreement with Takeda (TAK) in Decembe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/halozyme-announces-global-collaboration-license-agreement-with-takeda-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/halozyme-announces-global-collaboration-license-agreement-with-takeda-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HALO","BK4139","TAK","BK4007","LU0053671581.USD"],"gpt_icon":0},{"id":"2592413445","title":"Takeda Pharmaceuticals Shares Rise on Positive Psoriasis Treatment Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2592413445","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592413445?lang=en_us&edition=fundamental","pubTime":"2025-12-19 11:17","pubTimestamp":1766114220,"startTime":"0","endTime":"0","summary":"Shares of Takeda Pharmaceuticals rose after the Japanese pharmaceutical major announced positive results from clinical trials of its new treatment for plaque psoriasis.The stock climbed 4.3% in early Tokyo trade Friday to reach a three-month high before pulling back slightly. It is on course for its biggest single-day gain since April.The benchmark Nikkei Stock Average was last up 1.2%.Takeda's gains came after it said its drug candidate zasocitinib delivered positive results in Phase 3 studies, the final stage of clinical trials before regulatory approval.The new drug is designed to treat moderate to severe plaque psoriasis, a condition that causes raised, itchy and painful skin patches covered by scales. An estimated 64 million people globally have psoriasis with 80%-90% of them having plaque psoriasis specifically, medical studies show.The drug, delivered in a once-a-day pill, achieved complete or near-complete clearance of skin lesions in more than half of the trial participants, T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Takeda Pharmaceuticals Shares Rise on Positive Psoriasis Treatment Results","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2592272976","title":"Takeda Pharmaceutical's Potential Plaque Psoriasis Therapy Meets Endpoints in Phase 3 Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2592272976","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592272976?lang=en_us&edition=fundamental","pubTime":"2025-12-18 16:59","pubTimestamp":1766048376,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  said Thursday its drug zasocitinib for the treatment of adults with moderate-to-severe plaque psoriasis met primary and secondary endpoints in two phase 3 studies.The studies showed the superiority of zasocitinib compared with placebo for the two primary endpoints, including a global assessment criteria and the psoriasis area and severity index standard after 16 weeks, with \"significant\" response seen as early as week and improvement continuing through 24 weeks.The studies also met all 44 secondary endpoints, the company said.Zasocitinib was also generally well-tolerated, with no new safety signals identified, the company said.Plaque psoriasis is an autoimmune condition that causes thick patches on the skin and scalp.Takeda said it plans to submit a new drug application with the US Food and Drug Administration and other regulatory authorities beginning in 2026.Zasocitinib is also being studied compared with deucravacitinib in treating plaque psoriasis, as well as","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"1108419006","title":"INNOVENT BIO (01801) Completes Global Strategic Collaboration with Takeda Pharmaceutical and Issues 6.9138 Million Shares Under General Mandate","url":"https://stock-news.laohu8.com/highlight/detail?id=1108419006","media":"Stock News","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108419006?lang=en_us&edition=fundamental","pubTime":"2025-12-05 07:18","pubTimestamp":1764890315,"startTime":"0","endTime":"0","summary":"INNOVENT BIO (01801) announced the completion of its global strategic collaboration with Takeda Pharmaceutical Co Ltd (through its wholly-owned subsidiary Takeda Pharmaceuticals International AG)....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU2097828714.EUR","LU2097828474.EUR","LU0455707207.USD","TAK","LU2097828557.USD","LU2097828805.USD","LU2488822045.USD","BK1161","BK1589","LU0502904849.HKD","LU1969619763.USD","HK0000165453.HKD","BK1583","LU2328871848.SGD","01801","LU2242644610.SGD","LU2097828631.EUR"],"gpt_icon":0},{"id":"2585128462","title":"FDA Flags Antibody Risk After Child's Death Linked To Takeda's Enzyme Replacement Therapy For Rare Blood Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2585128462","media":"Benzinga_recent_news","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585128462?lang=en_us&edition=fundamental","pubTime":"2025-11-22 02:43","pubTimestamp":1763750580,"startTime":"0","endTime":"0","summary":"FDA reports rare neutralizing antibodies, including a pediatric death, in patients treated with Takeda's Adzynma for congenital TTP.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/21/Motala--Sweden--7-January-2023-Fda-Logo-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/21/Motala--Sweden--7-January-2023-Fda-Logo-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/fda/25/11/49012169/fda-flags-antibody-risk-after-childs-death-linked-to-takedas-enzyme-replacement-therapy-for-rare-blood-disorder","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/fda/25/11/49012169/fda-flags-antibody-risk-after-childs-death-linked-to-takedas-enzyme-replacement-therapy-for-rare-blood-disorder","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2585141552","title":"Takeda Pharmaceutical's Adzynma Under US FDA Probe Following Death of Pediatric Patient","url":"https://stock-news.laohu8.com/highlight/detail?id=2585141552","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585141552?lang=en_us&edition=fundamental","pubTime":"2025-11-21 22:50","pubTimestamp":1763736609,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical's  Adzynma is being investigated by the US Food and Drug Administration following the death of a pediatric patient related to the drug, which is intended to treat congenital thrombotic thrombocytopenic purpura, the regulator said Friday.\"Prior to treatment with Adzynma, this patient had severe allergic reactions to fresh frozen plasma,\" the FDA said. \"The patient presented with neurologic symptoms which progressed, and the presence of neutralizing antibodies to ADAMTS13 was identified approximately 10 months after starting prophylactic treatment with Adzynma.\"The FDA said the probe will investigate the risk of patients developing neutralizing antibodies with \"serious, including life-threatening or fatal, outcomes following treatment with Adzynma.\" It also said it will determine if additional regulatory action is needed.The FDA also said current assays cannot distinguish neutralizing antibodies to recombinant ADAMTS13 from neutralizing antibodies to endogenous ADAM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2584912234","title":"Immigration Declares 'No Safe Haven' in Indonesia for International Criminals Following Major Arrests","url":"https://stock-news.laohu8.com/highlight/detail?id=2584912234","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584912234?lang=en_us&edition=fundamental","pubTime":"2025-11-19 14:48","pubTimestamp":1763534888,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta-The Ministry of Immigration and Corrections has detained a high-profile fugitive from China and deported 27 foreign nationals suspected of operating a cybercrime syndicate. Acting Director General of Immigration Yuldi Yusman declared that there is no safe haven in Indonesia for international criminals.Yuldi stated that these operations demonstrate Indonesia's close cooperation with foreign governments. \"Indonesia is not a destination for international fugitives. We will continue to collaborate with national and international law enforcement agencies to ensure this,\" Yuldi said in a statement on Tuesday, November 18, 2025.Embezzlement Suspect Owning Rp2.2 Trillion Arrested in Batam","market":"us","thumbnail":"https://statik.tempo.co/data/2025/11/18/id_1442096/1442096_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/11/18/id_1442096/1442096_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2066970/immigration-declares-no-safe-haven-in-indonesia-for-international-criminals-following-major-arrests","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2066970/immigration-declares-no-safe-haven-in-indonesia-for-international-criminals-following-major-arrests","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2582117359","title":"Neurocrine Biosciences' Depressive Disorder Drug Fails to Meet Primary Goal in Phase 2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2582117359","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582117359?lang=en_us&edition=fundamental","pubTime":"2025-11-11 16:41","pubTimestamp":1762850517,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences (NBIX) said late Monday its phase 2 study evaluating the efficacy, safety and tolerability of experimental drug, NBI-1070770, in adults with major depressive disorder did not me","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0823416689.USD","LU2065171402.SGD","LU0320765992.SGD","LU2065169927.USD","NBIX","LU0889565916.HKD","LU2065170008.USD","LU0154245756.USD","BK4007","BK4139","LU0154245673.USD","LU2324357040.USD","LU0109394709.USD","LU2065171311.SGD","TAK"],"gpt_icon":0},{"id":"2581887559","title":"Takeda presents interim data from Phase 1b study of mezagitamab","url":"https://stock-news.laohu8.com/highlight/detail?id=2581887559","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581887559?lang=en_us&edition=fundamental","pubTime":"2025-11-08 00:10","pubTimestamp":1762531817,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced new interim data from the Phase 1b, open-label, proof-of-concept study of subcutaneous mezagitamab, an anti-CD38 monoclonal ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-presents-interim-data-from-phase-1b-study-of-mezagitamab-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-presents-interim-data-from-phase-1b-study-of-mezagitamab-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2579112177","title":"Asian Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2579112177","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579112177?lang=en_us&edition=fundamental","pubTime":"2025-10-30 22:38","pubTimestamp":1761835096,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were headed lower Thursday morning, declining 0.76% to 2,755.38 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by pet-focused platform Boqii  and fintech firm Pintec Technology , which climbed 10% and 6.4%, respectively. They were followed by biopharmaceutical company Zai Lab  and fintech company Jiayin Group , which increased 3.4% and 3.3%, respectively.The decliners from North Asia were led by online entertainment company Bilibili  and polysilicon manufacturer Daqo New Energy , which fell 5.1% and 4.8%, respectively. They were followed by pharmaceutical company Takeda Pharmaceutical Company  and thin-film liquid display maker LG Display , which were down 4.3% and 4.1%, respectively.From South Asia, the only gainers were pharmaceutical company Dr. Reddy's Laboratories  and telecommunications operator PLDT , which were up 0.8% and 0.6%, respectively.The decliners from South Asia were led by IT firm Sify","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4207","LU0231203729.USD","DQ","LU0390135332.USD","ZLAB","INFY","BK4077","PT","BILI","BK4115","LU1854103824.USD","BK4510","LU2663582299.SGD","SIFY","LU0868486357.SGD","LU2265009873.SGD","LU0229945570.USD","BQ","LU1267930656.SGD","LU0797268264.HKD","RDY","BK4148","BK4554","LU0390135506.SGD","LU0918141705.HKD","BK7016","BK4509","HDB","RDY.AU","BK4548","TAK","AFG","LU2087589342.USD","BK4531","BK4532","LU0287143357.SGD","LU0348814723.USD","LU0300738514.USD","LU0536402901.SGD","LU0390134368.USD","LU0862451753.SGD","LU1366334578.USD","LU1805238398.USD","BK4588","LPL","JFIN","PHI","TLK","LU0541502299.USD","BK4139"],"gpt_icon":1},{"id":"1112007293","title":"Stock Track | Takeda Pharmaceutical Plummets 5.08% as Q2 Earnings Miss Estimates and Company Lowers Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1112007293","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112007293?lang=en_us&edition=fundamental","pubTime":"2025-10-30 21:51","pubTimestamp":1761832275,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co Ltd (NYSE:TAK) saw its stock price plummet 5.08% in pre-market trading on Thursday following the release of its second-quarter earnings report and updated full-year outlook....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TAK"],"gpt_icon":0},{"id":"2579111892","title":"Takeda Pharmaceutical's Fiscal Q2 Core Earnings, Revenue Decline; Fiscal 2025 Outlook Trimmed","url":"https://stock-news.laohu8.com/highlight/detail?id=2579111892","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579111892?lang=en_us&edition=fundamental","pubTime":"2025-10-30 17:32","pubTimestamp":1761816763,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  reported fiscal Q2 core earnings Thursday of 128 Japanese yen  per share, down from 134 yen a year earlier.Two analysts polled by FactSet expected 66.98 yen.Revenue for the quarter ended Sept. 30 was 1.113 trillion yen, compared with 1.176 trillion yen a year earlier.Analysts polled by FactSet expected 1.197 trillion yenThe company said it now expects fiscal 2025 core earnings of 479 yen per share, from 485 yen previously. Analysts polled by FactSet expect 246.9 yen.Takeda also lowered its fiscal 2025 revenue guidance to 4.5 trillion yen, from 4.53 trillion yen previously. Analysts polled by FactSet expect 4.582 trillion yen.Shares of Takeda Pharmaceutical were down nearly 2% in recent premarket activity Thursday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2579846118","title":"Takeda Swings to Loss on Impairment Charges, Cuts Guidance -- Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2579846118","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579846118?lang=en_us&edition=fundamental","pubTime":"2025-10-30 17:24","pubTimestamp":1761816240,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical cut its annual earnings forecasts as impairment charges for discontinued drug research pushed the company into the red in the latest quarter.The Japanese drugmaker said Thursday that it swung to a net loss of 11.8 billion yen, equivalent to $77.3 million, for the three months ended September, from net profit of Y92.0 billion in the year-earlier period. The result was worse than the Y65.2 billion net profit estimate in a poll of analysts by data provider Visible Alpha.Takeda recorded impairment charges of about Y58 billion in its second quarter related to the cell-therapy research it discontinued as part of a strategic portfolio review.For the fiscal year ending March, it projected revenue to decline 1.8% to Y4.500 trillion and net profit to increase 42% to Y153.00 billion. The company previously expected revenue of Y4.530 trillion and net profit of Y228.00 billion.Second-quarter revenue dropped 5.4% to Y1.113 trillion. Sales of plasma-derived products declined 2.9","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Takeda Swings to Loss on Impairment Charges, Cuts Guidance -- Update","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2579937391","title":"Press Release: Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2579937391","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579937391?lang=en_us&edition=fundamental","pubTime":"2025-10-30 15:04","pubTimestamp":1761807840,"startTime":"0","endTime":"0","summary":"--  First Half Revenue Declined 3.9% at Constant Exchange Rate , -6.9%. at Actual Exchange Rates , Impacted by Generic Erosion of VYVANSE. --  Core Operating Profit Declined 8.8% at CER in the First Half,Reflecting Revenue Performance and Product Mix; Impact Partially Offset. --  First Half Reported Operating Profit  Impacted by. \"Takeda's fiscal year 2025 first half results are consistent with our expectations for core business progress in this year of transition to a new phase focusing on new product launches. Our updated full-year outlook reflects impairment charges associated with strategic pipeline decisions taken in Q2, as well as transactional FX.\"We are confident in our business fundamentals as we look to the second half of this transitional year for Takeda.\". FINANCIAL HIGHLIGHTS for FY2025 H1 Ended September 30, 2025","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AER","LU1098665638.USD","R","BK4232","BK4007","BK4572","BK4104","LU0211331839.USD","BK4022","TAK","LU0109981661.USD"],"gpt_icon":0},{"id":"1193166864","title":"Zhao Yin International Raises Target Price for INNOVENT BIO (01801) to HKD 110.62 Following Strategic Partnership with Takeda Pharmaceutical Co Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=1193166864","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193166864?lang=en_us&edition=fundamental","pubTime":"2025-10-24 16:31","pubTimestamp":1761294691,"startTime":"0","endTime":"0","summary":"Zhao Yin International has published a research report indicating that INNOVENT BIO (01801) has entered into a global strategic partnership with Takeda Pharmaceutical Co Ltd, covering several key...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828714.EUR","LU2328871848.SGD","01801","LU2242644610.SGD","LU0455707207.USD","LU2097828805.USD","LU0502904849.HKD","LU2097828474.EUR","TAK","BK1583","LU1969619763.USD","LU2097828557.USD","LU2488822045.USD","BK4007","LU2097828631.EUR","BK1589","BK1161"],"gpt_icon":0},{"id":"1174450846","title":"Haitong International: Innovent Biologics (01801) and Takeda Pharmaceutical Co Ltd Reach $11.4 Billion Deal, Collaboration on Commercialization Looks Promising","url":"https://stock-news.laohu8.com/highlight/detail?id=1174450846","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174450846?lang=en_us&edition=fundamental","pubTime":"2025-10-23 17:31","pubTimestamp":1761211897,"startTime":"0","endTime":"0","summary":"According to Haitong International's research report, Innovent Biologics (01801) has established a global strategic partnership with Takeda Pharmaceutical Co Ltd, encompassing two late-stage...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2097828474.EUR","LU2097828805.USD","LU1969619763.USD","01801","BK1583","LU2097828714.EUR","LU2488822045.USD","LU0455707207.USD","LU2242644610.SGD","BK4007","LU2097828557.USD","LU2328871848.SGD","BK1589","TAK","LU0502904849.HKD","LU2097828631.EUR"],"gpt_icon":0},{"id":"1169882507","title":"LCB: INNOVENT BIO (01801) and Takeda Pharmaceutical's Collaboration Positively Impacts Product Development, Target Price Raised to HKD 120.1","url":"https://stock-news.laohu8.com/highlight/detail?id=1169882507","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169882507?lang=en_us&edition=fundamental","pubTime":"2025-10-23 16:04","pubTimestamp":1761206665,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，里昂发布研报称，信达生物(01801)与日本武田制药(Takeda Pharmaceutical Co...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","LU2488822045.USD","LU2328871848.SGD","BK1589","LU0502904849.HKD","LU2097828631.EUR","LU2097828805.USD","LU2097828474.EUR","01801","BK1161","LU2242644610.SGD","LU0455707207.USD","LU1969619763.USD","LU2097828714.EUR","TAK","LU2097828557.USD","BK4007"],"gpt_icon":0},{"id":"1153924134","title":"Hong Kong Stock Market Update | Innovent Bio and Takeda Pharmaceutical Reach Global Strategic Cooperation and Issue Shares Under General Authorization","url":"https://stock-news.laohu8.com/highlight/detail?id=1153924134","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153924134?lang=en_us&edition=fundamental","pubTime":"2025-10-22 23:08","pubTimestamp":1761145721,"startTime":"0","endTime":"0","summary":"【Major Developments】Innovent Bio (01801) has established a global strategic cooperation with Takeda Pharmaceutical Co Ltd and will issue shares under general authorization. China Unicom (00762) plans...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TAK","BK1583","00293","SGXZ90724238.SGD","LU2488822045.USD","SG9999001051.SGD","LU2328871848.SGD","SG9999002463.SGD","BK1123","06181","LU2097828805.USD","LU2097828714.EUR","LU2242644610.SGD","BK1133","BK1506","BK1544","LU2097828557.USD","BK1589","BK1227","BK1536","BK1561","LU0502904849.HKD","LU0455707207.USD","LU1969619763.USD","BK1161","00762","LU2097828474.EUR","LU2097828631.EUR","01801"],"gpt_icon":1},{"id":"2577517903","title":"Takeda Forms $1.2 Billion Strategic Partnership with Innovent Biologics","url":"https://stock-news.laohu8.com/highlight/detail?id=2577517903","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577517903?lang=en_us&edition=fundamental","pubTime":"2025-10-22 17:08","pubTimestamp":1761124097,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  said late Tuesday it signed a license and collaboration agreement with Innovent Biologics, covering two of the latter's late-stage oncology medicines.Takeda will hold the license to develop, manufacture, and commercialize IBI363 and IBI343 globally, except in China, Hong Kong, Macau, and Taiwan, in exchange for a $1.2 billion upfront payment to Innovent Biologics upon closing.The payment includes a $100 million equity investment in Innovent Biologics, which will also be entitled to additional payments from profit sharing, royalties, and achievement of certain milestones, Takeda said.Takeda also said the deal grants it an exclusive option to license IBI3001, an early-stage investigational oncology medicine, from Innovent Biologics.The company said it plans to establish manufacturing for the investigational medicines in the US.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TAK"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":73,"code":"91000000","status":"200"}]}}